Impact of Cigarette Smoking on the Gastrointestinal Tract Inflammation: Opposing Effects in Crohn's Disease and Ulcerative Colitis

Cigarette smoking is a major risk factor for gastrointestinal disorders, such as peptic ulcer, Crohn's disease (CD), and several cancers. The mechanisms proposed to explain the role of smoking in these disorders include mucosal damage, changes in gut irrigation, and impaired mucosal immune resp...

Full description

Saved in:
Bibliographic Details
Published in:Frontiers in immunology Vol. 9; p. 74
Main Authors: Berkowitz, Loni, Schultz, Bárbara M, Salazar, Geraldyne A, Pardo-Roa, Catalina, Sebastián, Valentina P, Álvarez-Lobos, Manuel M, Bueno, Susan M
Format: Journal Article
Language:English
Published: Switzerland Frontiers Media S.A 30-01-2018
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Cigarette smoking is a major risk factor for gastrointestinal disorders, such as peptic ulcer, Crohn's disease (CD), and several cancers. The mechanisms proposed to explain the role of smoking in these disorders include mucosal damage, changes in gut irrigation, and impaired mucosal immune response. Paradoxically, cigarette smoking is a protective factor for the development and progression of ulcerative colitis (UC). UC and CD represent the two most important conditions of inflammatory bowel diseases, and share several clinical features. The opposite effects of smoking on these two conditions have been a topic of great interest in the last 30 years, and has not yet been clarified. In this review, we summarize the most important and well-understood effects of smoking in the gastrointestinal tract; and particularly, in intestinal inflammation, discussing available studies that have addressed the causes that would explain the opposite effects of smoking in CD and UC.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
Specialty section: This article was submitted to Mucosal Immunity, a section of the journal Frontiers in Immunology
Reviewed by: Nadia Corazza, University of Bern, Switzerland; Gianluca Matteoli, KU Leuven, Belgium
Edited by: Eric Cox, Ghent University, Belgium
ISSN:1664-3224
1664-3224
DOI:10.3389/fimmu.2018.00074